Lisa Bollinger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lisa Bollinger
Polaryx Therapeutics, Inc. reported in an 8-K filed July 21, 2026 that Lisa Bollinger resigned as Chief Medical Officer, effective July 19, 2026. The proxy statement of Polaryx Therapeutics, Inc. reports total compensation of $482,500 for Lisa Bollinger in fiscal 2025, including a base salary of $62,500. Lisa Bollinger has spoken on 1 investor event across 1 company, most recently for Polaryx Therapeutics, Inc. on April 16, 2026.
“On July 19, 2026, Lisa Bollinger, MD, Chief Medical Officer of Polaryx Therapeutics, Inc. (the “Company”), resigned from her position with the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Polaryx Therapeutics, Inc. (PLYX)
Transcript header (unverified)
Start not stated–2026-07-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Polaryx Therapeutics, Inc. (PLYX) | Chief Medical Officer\ | $62,500 | $482,500 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.